Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Romanian Journal of Internal Medicine

4 Issues per year

Open Access
See all formats and pricing
In This Section

Illicit drugs and their impact on cardiovascular pathology

Elisabeta Bădilă
  • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • “Floreasca” Emergency Clinical Hospital, Bucharest, Romania
/ Mihaela Hostiuc
  • Corresponding author
  • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • “Floreasca” Emergency Clinical Hospital, Bucharest, Romania
  • Email:
/ Emma Weiss
  • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • “Floreasca” Emergency Clinical Hospital, Bucharest, Romania
/ Daniela Bartoş
  • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
  • “Floreasca” Emergency Clinical Hospital, Bucharest, Romania
Published Online: 2015-10-14 | DOI: https://doi.org/10.1515/rjim-2015-0029


The use of illicit drugs has dramatically increased during the past years. Consequently, the number of presentations at the emergency departments due to the adverse effects of the illicit drugs has also increased. This review discusses the cardiovascular effects of cocaine, opiates and opioids, cannabinoids, amphetamines, methamphetamines and hallucinogens as we consider that it is essential for a clinician to be aware of them and understand their mechanisms in order to optimize the therapeutic management.

Utilizarea drogurilor a crescut alarmant în ultimii ani. Astfel că numărul de prezentări în cadrul departamentelor de primiri urgenţă datorate efectelor adverse ale acestora a crescut şi el. Acest articol tip review discută efectele asupra sistemului cardiovascular al cocainei, opioidelor, canabinoidelor, metamfetaminelor şi halucinogenelor deoarece clinicianul trebuie să le cunoască, să le înţeleagă mecanismul fiziopatologic pentru a îmbunătăţi abordarea terapeutică.

Keywords: illicit drugs; cocaine; cardiovascular effects


  • 1. www.drugwarfacts.org

  • 2. WILBERT-LAMPEN U, SELIGER C, ZILKER T, ARENDT RM. Cocaine Increases the Endothelial Release of Immunoreactive Endothelin and Its Concentrations in Human Plasma and Urine: Reversal by Coincubation With σ-Receptor Antagonists. Circulation 1998, 98(5):385-390. [Crossref]

  • 3. MO W, SINGH AK, ARRUDA JAL, DUNEA G. Role of Nitric Oxide in Cocaine-Induced Acute Hypertension. American Journal of Hypertension 1998, 11(6):708-714. [Crossref]

  • 4. LANGE RA, HILLIS LD. Cardiovascular Complications of Cocaine Use. New England Journal of Medicine 2001, 345(5):351-358.

  • 5. HEESCH CM, WILHELM CR, RISTICH J, ADNANE J, BONTEMPO FA, WAGNER WR. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart 2000, 83(6):688-695.

  • 6. RINDER HM, AULT KA, JATLOW PI, KOSTEN TR, SMITH BR. Platelet alpha-granule release in cocaine users. Circulation 1994, 90(3):1162-1167. [Crossref]

  • 7. SIEGEL AJ, MENDELSON JH, SHOLAR MB, MCDONALD JC, LEWANDROWSKI KB, LEWANDROWSKI EL, LIPINSKA I, RIDKER PM, TOFLER GH. Effect of cocaine usage on C-reactive protein, von Willebrand factor, and fibrinogen. American Journal of Cardiology, 89(9):1133-1135.

  • 8. SCHWARTZ BG, REZKALLA S, KLONER RA. Cardiovascular Effects of Cocaine. Circulation 2010, 122(24):2558-2569.

  • 9. GUO J, GANG H, ZHANG S. Molecular Determinants of Cocaine Block of Human Ether-á-go-go-Related Gene Potassium Channels. Journal of Pharmacology and Experimental Therapeutics 2006, 317(2):865-874.

  • 10. KARCH SB. The pathology of drug abuse. CRC Press Boca Raton; 1996.

  • 11. QURESHI AI, SURI MFK, GUTERMAN LR, HOPKINS LN. Cocaine Use and the Likelihood of Nonfatal Myocardial Infarction and Stroke: Data From the Third National Health and Nutrition Examination Survey. Circulation 2001, 103(4):502-506.

  • 12. HOLLANDER JE, HOFFMAN RS. Cocaine-induced myocardial infarction: An analysis and review of the literature. Journal of Emergency Medicine, 10(2):169-177. [Crossref]

  • 13. MOHAMAD T, NIRAJ A, FARAH J, OBIDEEN M, BADHEKA A, KONDUR A, THATAI D, AFONSO L. Spectrum of electrocardiographic and angiographic coronary artery disease findings in patients with cocaine-associated myocardial infarction. Coronary artery disease 2009, 20(5):332-336. [Crossref] [Web of Science]

  • 14. HOLLANDER JE, HOFFMAN RS, BURSTEIN JL, et al. Cocaine-associated myocardial infarction: Mortality and complications. Archives of Internal Medicine 1995, 155(10):1081-1086.

  • 15. HSUE PY, SALINAS CL, BOLGER AF, BENOWITZ NL, WATERS DD. Acute Aortic Dissection Related to Crack Cocaine. Circulation 2002, 105(13):1592-1595. [Crossref]

  • 16. DEAN JH, WOZNICKI EM, O'GARA P, MONTGOMERY DG, TRIMARCHI S, MYRMEL T, PYERITZ RE, HARRIS KM, SUZUKI T, BRAVERMAN AC et al. Cocaine-related Aortic Dissection: Lessons from the International Registry of Acute Aortic Dissection. The American Journal of Medicine, 127(9):878-885. [Web of Science]

  • 17. EAGLE KA, ISSELBACHER EM, DESANCTIS RW, INVESTIGATORS tIRfAD. Cocaine-Related Aortic Dissection in Perspective. Circulation 2002, 105(13):1529-1530. [Crossref]

  • 18. CHAMBERS HF, MORRIS DL, TÄUBER MG, MODIN G. Cocaine Use and the Risk for Endocarditis in Intravenous Drug Users. Annals of Internal Medicine 1987, 106(6):833-836. [Crossref]

  • 19. BRECKLIN CS, GOPANIUK-FOLGA A, KRAVETZ T, SABAH S, SINGH A, ARRUDA JAL, DUNEA G. Prevalence of Hypertension in Chronic Cocaine Users. American Journal of Hypertension 1998, 11(11):1279-1283. [Crossref]

  • 20. CATRAVAS JD, WATERS IW. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. Journal of Pharmacology and Experimental Therapeutics 1981, 217(2):350-356.

  • 21. BROGAN IIIWC, LANGE RA, KIM AS, MOLITERNO DJ, HILLIS LD. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. Journal of the American College of Cardiology 1991, 18(2):581-586. [Crossref]

  • 22. SOFUOGLU M, BROWN S, BABB DA, PENTEL PR, HATSUKAMI DK. Carvedilol affects the physiological and behavioral response to smoked cocaine in humans. Drug & Alcohol Dependence, 60(1):69-76.

  • 23. MARTIN-SCHILD S, ALBRIGHT KC, MISRA V, PHILIP M, BARRETO AD, HALLEVI H, GROTTA JC, SAVITZ SI. Intravenous Tissue Plasminogen Activator in Patients with Cocaine-Associated Acute Ischemic Stroke. Stroke; a journal of cerebral circulation 2009, 40(11):3635-3637.

  • 24. AFSHARI R, MAXWELL SRJ, WEBB DJ, BATEMAN DN. Morphine is an arteriolar vasodilator in man. British Journal of Clinical Pharmacology 2009, 67(4):386-393. [Web of Science]

  • 25. LIU C, DAI R, YU R, XU J. Morphine preconditioning, cardioprotection and left ventricular remodelling in rabbits. Acta Cardiol 2011, 66(3):341-348. [Web of Science]

  • 26. TINTINALLI JE, STAPCZYNSKI JS. Tintinalli's emergency medicine: a comprehensive study guide. McGraw-Hill, New York; 2011.

  • 27. KOHRS R, DURIEUX ME. Ketamine: Teaching an old drug new tricks. Anesthesia & Analgesia 1998, 87(5):1186-1193.

  • 28. SPRUNG MDPJ, SCHUETZ BSSHANNON M, STEWART MDROBERT W, MORAVEC PCHRISTINE S. Effects of ketamine on the contractility of failing and nonfailing human heart muscles in vitro. The Journal of the American Society of Anesthesiologists 1998, 88(5):1202-1210. [Crossref]

About the article

Received: 2015-05-31

Published Online: 2015-10-14

Published in Print: 2015-09-01

Citation Information: Romanian Journal Of Internal Medicine, ISSN (Online) 1220-4749, DOI: https://doi.org/10.1515/rjim-2015-0029. Export Citation

© 2015 Elisabeta Bădilă et al., published by De Gruyter Open. This chapter is distributed under the terms of the Creative Commons Attribution 4.0 Public License. (CC BY 4.0)

Comments (0)

Please log in or register to comment.
Log in